PEDIATRICS Vol. 78 No. 4 October 1986, pp. 723-727
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Guess, H. A.
Right arrow Articles by Kurland, L. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Guess, H. A.
Right arrow Articles by Kurland, L. T.

Population-Based Studies of Varicella Complications

H. A. Guess MD, PhD1, D. D. Broughton MD1, L. J. Melton III MD, MPH1, and L. T. Kurland MD, DrPH1

1 From Merck Sharp & Dohme Research Laboratories, West Point, Pennsylvania, and Departments of Medical Statistics and Epidemiology and Pediatrics, Mayo Clinic, Rochester, Minnesota

Population-based data on vanicella complications are presented using information both from national sample surveys of hospitalizations and physician office visits and from reviews of medical records for all cases occurring within one community (Olmsted County, Minnesota) during a specified period. Acute cerebellar ataxia is the most common neurologic complication of varicella and occurs about once in 4,000 vanicella cases among children younger than 15 years of age. Among adults, varicella pneumonia is the most common complication and results in hospitalization about once in every 400 varicella cases. Overall, varicella accounts for approximately 4,000 hospitalizations and 364,000 physician office visits annually in the United States and represents an important continuing source of childhood and adult morbidity.




This article has been cited by other articles:


Home page
 Arch. Dis. Child.Home page
Should the UK introduce varicella vaccine?
Arch. Dis. Child., December 1, 2007; 92(12): 1051 - 1052.


Home page
 Arch. Dis. Child.Home page
Severe complications of chickenpox in hospitalised children in the UK and Ireland
Arch. Dis. Child., December 1, 2007; 92(12): 1062 - 1066.


Home page
 J Child NeurolHome page
K. Aydin, A. Sert, E. A. Guze, and D. A. Kiresi
Acute Childhood Hemiplegia Associated With Chickenpox and Elevated Anticardiolipin Antibody
J Child Neurol, October 1, 2006; 21(10): 890 - 893.
[Abstract] [PDF]

Home page
 J. Clin. Microbiol.Home page
G. H. Dayan, M. S. Panero, R. Debbag, A. Urquiza, M. Molina, S. Prieto, M. del Carmen Perego, G. Scagliotti, D. Galimberti, G. Carroli, et al.
Varicella Seroprevalence and Molecular Epidemiology of Varicella-Zoster Virus in Argentina, 2002
J. Clin. Microbiol., December 1, 2004; 42(12): 5698 - 5704.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
J. F. Seward, B. M. Watson, C. L. Peterson, L. Mascola, J. W. Pelosi, J. X. Zhang, T. J. Maupin, G. S. Goldman, L. J. Tabony, K. G. Brodovicz, et al.
Varicella Disease After Introduction of Varicella Vaccine in the United States, 1995-2000
JAMA, February 6, 2002; 287(5): 606 - 611.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
C. Ziebold, R. von Kries, R. Lang, J. Weigl, and H. J. Schmitt
Severe Complications of Varicella in Previously Healthy Children in Germany: A 1-Year Survey
Pediatrics, November 1, 2001; 108(5): e79 - 79.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Microbiol. Rev.Home page
P. H. Dennehy
Active Immunization in the United States: Developments over the Past Decade
Clin. Microbiol. Rev., October 1, 2001; 14(4): 872 - 908.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child.Home page
S A Skull and E E L Wang
Current topic: Varicella vaccination{---}a critical review of the evidence
Arch. Dis. Child., August 1, 2001; 85(2): 83 - 90.
[Full Text] [PDF]

Home page
 PediatricsHome page
Committee on Infectious Diseases
Varicella Vaccine Update
Pediatrics, January 1, 2000; 105(1): 136 - 141.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
B. Law, C. Fitzsimon, L. Ford-Jones, J. McCormick, and M. Rivière
Cost of Chickenpox in Canada: Part II. Cost of Complicated Cases and Total Economic Impact
Pediatrics, July 1, 1999; 104(1): 7 - 14.
[Abstract] [Full Text]